Table 3.
Variable | Late-stage model |
Female breast model |
Colorectal model |
Cervical model |
Prostate model |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | |
Sex | |||||||||||||||
Female | 0.81 | 0.80, 0.82 | <0.01 | – | – | – | 0.93 | 0.92, 0.95 | <0.01 | – | – | – | – | – | – |
Male | REF | REF | |||||||||||||
Age, years | |||||||||||||||
<40 | 0.27 | 0.24, 0.30 | <0.01 | 0.25 | 0.22, 0.27 | <0.01 | 0.25 | 0.23, 0.28 | <0.01 | 0.17 | 0.16, 0.19 | <0.01 | 0.36 | 0.32, 0.40 | <0.01 |
40–49 | 0.54 | 0.52, 0.57 | <0.01 | 0.48 | 0.46, 0.50 | <0.01 | 0.58 | 0.56, 0.61 | <0.01 | 0.47 | 0.45, 0.49 | <0.01 | 0.66 | 0.63, 0.68 | <0.01 |
65–74 | 1.83 | 1.79, 1.87 | <0.01 | 1.88 | 1.84, 1.92 | <0.01 | 1.70 | 1.66, 1.73 | <0.01 | 1.87 | 1.83, 1.91 | <0.01 | 1.70 | 1.67, 1.74 | <0.01 |
75+ | 2.47 | 2.42, 2.52 | <0.01 | 2.41 | 2.36, 2.46 | <0.01 | 1.32 | 1.29, 1.35 | <0.01 | 2.39 | 2.34, 2.44 | <0.01 | 2.44 | 2.39, 2.49 | <0.01 |
50–64 | REF | REF | REF | REF | REF | ||||||||||
Race-ethnicity | |||||||||||||||
Hispanic | 0.94 | 0.91, 0.97 | <0.01 | 0.96 | 0.93, 1.00 | <0.01 | 0.89 | 0.86, 0.92 | <0.01 | 0.91 | 0.88, 0.94 | <0.01 | 0.94 | 0.91, 0.97 | <0.01 |
AI/AN | 1.15 | 1.02, 1.29 | <0.01 | 1.15 | 1.02, 1.29 | <0.01 | 0.96 | 0.85, 1.08 | <0.01 | 1.10 | 0.98, 1.24 | <0.01 | 1.15 | 1.02, 1.29 | <0.01 |
Asian | 0.85 | 0.80, 0.90 | <0.01 | 0.84 | 0.79, 0.89 | <0.01 | 0.72 | 0.68, 0.76 | <0.01 | 0.81 | 0.77, 0.86 | <0.01 | 0.89 | 0.84, 0.94 | <0.01 |
Black | 1.34 | 1.31, 1.38 | <0.01 | 1.40 | 1.37, 1.43 | <0.01 | 1.38 | 1.35, 1.41 | <0.01 | 1.33 | 1.30, 1.36 | <0.01 | 1.29 | 1.27, 1.32 | <0.01 |
Other | 0.15 | 0.13, 0.19 | <0.01 | 0.14 | 0.11, 0.16 | <0.01 | 0.22 | 0.18, 0.26 | <0.01 | 0.13 | 0.11, 0.15 | <0.01 | 0.10 | 0.08, 0.12 | <0.01 |
White | REF | REF | REF | REF | REF | ||||||||||
Cancer type | |||||||||||||||
Late stage | 1.32 | 1.30, 1.35 | <0.01 | – | – | – | – | – | – | – | – | – | – | – | – |